Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      118 trials found

      Recruiting (118)
      Not yet recruiting
      Recruiting
      NCT06215118
      A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

      Multiple Myeloma

      Male or Female
      18+ years
      34study location(s)
      Recruiting
      NCT05317416
      Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

      Multiple Myeloma

      Male or Female
      18+ years
      221study location(s)
      Recruiting
      NCT06152575
      MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

      Multiple Myeloma

      Male or Female
      18+ years
      211study location(s)
      Recruiting
      NCT05675449
      A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

      Multiple Myeloma

      Male or Female
      18+ years
      32study location(s)
      Recruiting
      NCT06137742
      A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

      Pulmonary Arterial Hypertension

      Male or Female
      18 - 65 years
      27study location(s)
      Recruiting
      NCT05070845
      Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

      Primary Immune Thrombocytopenia

      Male or Female
      18 - 70 years
      28study location(s)
      Recruiting
      NCT06551324
      A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

      Metastatic Castrate Resistant Prostate Cancer (mCRPC)

      Males
      18+ years
      202study location(s)
      Recruiting
      NCT05895786
      A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

      Myositis

      Male or Female
      18+ years
      127study location(s)
      Recruiting
      NCT04624230
      Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

      Ulcerative Colitis

      Male or Female
      2 - 17 years
      77study location(s)
      Recruiting
      NCT05879718
      A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

      Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous

      Male or Female
      18 - 75 years
      36study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting (118)
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.